Active, Not Recruiting
A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)
NCT05885464
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- University of Chicago Chicago, Illinois, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States